DistaSense® and Exacerbations of COPD
Research type
Research Study
Full title
Non-contact Proactive Remote Monitoring to Facilitate Early Detection of Exacerbations in Chronic Obstructive Pulmonary Disease (COPD)
IRAS ID
316851
Contact name
John Hurst
Contact email
Sponsor organisation
Life Detection Technologies
Clinicaltrials.gov Identifier
Duration of Study in the UK
1 years, 0 months, 1 days
Research summary
Chronic Obstructive Pulmonary Disease (COPD) is a very common lung condition. People living with COPD are prone to chest infections called exacerbations. Earlier detection of exacerbations is important because it would allow earlier treatment. We aim to detect an exacerbation before the person recognises they are unwell by monitoring their heart rate and breathing rate whilst they are asleep. We will do this using a mattress pad device called 'DistaSense®'. The mattress pad will be used at home. One hundred people will be monitored for up to 12 months. Data from the pad is not being used to change care, in this study we are only assessing the potential for the pad to provide earlier detection of exacerbations.
REC name
London - Camberwell St Giles Research Ethics Committee
REC reference
22/LO/0923
Date of REC Opinion
3 Feb 2023
REC opinion
Further Information Favourable Opinion